Urinary Incontinence Market Research by Expert: Growth Rate, Industry Statistics and Forecasts to 2028

Comments · 95 Views

Urinary Incontinence Market Size – USD 2.52 Billion in 2020, Market Growth – at a CAGR of 7.6%, Market Trends – Advancements in neuromodulation therapies for the treatment of urinary incontinence

The global urinary incontinence market size is expected to reach USD 4.53 Billion in 2028 at a CAGR of 7.6% during the forecast period, according to the latest report by Reports and Data. Increasing incidence of urinary incontinence (UI) among women across the globe, technological advancements in urinary incontinence devices, improvements in health policies and insurance coverage, and growing awareness among patients regarding severity of the medical condition are key factors expected to drive market revenue growth over the forecast period. In addition, development of advanced surgical and non-invasive therapies, availability of wide range of treatment modalities for urinary incontinence, and rising number of initiatives to raise awareness of UI are some other key factors expected to further fuel revenue growth of the market going ahead.

Urinary incontinence is a common and distressing medical condition and is defined as involuntary or abnormal urine loss caused due to lower urinary tract dysfunction, chronic conditions, or medications. Urinary incontinence can have serious negative effects on physical function, psychological health, and quality of life for patients. It can limit mobility of patients and social interactions and can lead to depression in severe cases. Neglected urinary incontinence can lead to systemic infections, skin problems, and skin wounds, which further adds other physical morbidities to patients who are already suffering from numerous symptoms. Urinary incontinence is recognized as a priority health issue by the World Health Organization and has emphasized the need for proper attention from all healthcare providers to develop effective management techniques for urinary incontinence. It also poses a significant economic burden to the individual and healthcare system, and this has further boosted demand for robust treatment options, UI-specific tools to enhance patient outcomes, and introduction of advanced surgical interventions. This can, in turn, fuel revenue growth of the market going ahead.

Treatment of incontinence can vary with the type of incontinence, which makes it important to accurately identify the specific type of incontinence. Urinary incontinence is classified into three main types: stress UI, urge UI, and mixed UI. In recent years, treatment options for stress and urge urinary incontinence have advanced and aim to prevent involuntary loss of urine caused due to increased intra-abdominal pressure occurring during physical activity. Advancements in and rapid adoption of non-surgical therapies such as behavioral therapy and drug therapy are some other factors expected to drive market growth. However, lack of awareness about available treatment modalities, absence of favorable reimbursement policies in developing countries, and social stigma surrounding this condition are some key factors that can hamper market growth to a certain extent going ahead.

Market Overview:

The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviors are shifting in a variety of ways, from the growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.

Key Players covered in this report are

Covidien plc (Medtronic), Coloplast, Boston Scientific Corporation, C. R. Bard, Inc., ConvaTec Group Plc, Ethicon, Inc., Caldera Medical Inc., Cook Medical, Prosurg, Inc., and Cogentix Medical Inc.

Type Outlook (Revenue, USD Billion, 2018-2028)

  • Urge Incontinence
  • Overflow Incontinence
  • Stress Incontinence
  • Functional Incontinence
  • Mixed Urinary Incontinence
  • Total Incontinence
  • Others

Devices Outlook (Revenue, USD Billion; 2018-2028)

  • Electrical Stimulation Devices
    • Non-implantable
    • Implantable
  • Urethral Bulking Agents
  • Urinary Catheters
    • Foley
      • Antimicrobial Foley Catheters
    • Suprapubic
    • Intermittent
  • Neuromodulation Devices
  • Others

End-Use Outlook (Revenue, USD Billion; 2018-2028)

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Use
  • Others

Based on Region market is segmented into:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East Africa

Request a sample Report on the Urinary Incontinence Market @ https://www.reportsanddata.com/request-customization-form/2741 

Major Points covered in this report are as below:

• The Urinary Incontinence industry development trends and marketing channels are analyzed. The feasibility of new investment projects is assessed and overall research conclusions are offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes, and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue, and gross margins.

• The Urinary Incontinence Market report provides key statistics on the market status of the Urinary Incontinence manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.